United States Biotechnology & Medical Research

Veracyte Inc (VCYT)

Track

Over the last 90 days, Veracyte Inc. has seen significant insider selling, with a net value of -$1,089,624. Notably, the CEO, CFO, and other officers have engaged in planned and proposed sales totaling millions. This activity occurred following a strong earnings report where the company beat expectations.

Top insider sells (90, 60, 30d)

Top executive sells (30d)

Featured in screeners

Top insider sells

Top executive sells

Stock chart

Ticker: VCYT Exchange: NMS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Stapley Marc

Chief Executive Officer

1 sale — total 100,000 USD

Planned sale 4 Jun 2026

Value US$745,922.01 | Price 173.23 | Shares 5,387

Leite John

Global Chief Commercial Off

1 sale — total 100,000 USD

Planned sale 4 Jun 2026

Value US$4,416,297.06 | Price 403.65 | Shares 50,014

McGuire Annie

EVP, General Counsel

2 sales — total 200,000 USD

Planned sale 4 Jun 2026

Value US$100,000.00 | Price 50.12 | Shares 1,000

Planned sale 4 Jun 2026

Value US$100,000.00 | Price 49.31 | Shares 1,000

Chambers Rebecca

Chief Financial Officer

2 sales — total 200,000 USD

Planned sale 4 Jun 2026

Value US$100,000.00 | Price 50.09 | Shares 1,000

Planned sale 4 Jun 2026

Value US$100,000.00 | Price 49.28 | Shares 1,000

ANN MCGUIRE

Officer

1 sale — total 100,000 USD

Proposed sale 4 Jun 2026

Value US$100,000.00 | Price 48.69 | Shares 1,000

John Leite

Officer

1 sale — total 100,000 USD

Proposed sale 4 Jun 2026

Value US$100,000.00 | Price 48.69 | Shares 1,000

MARC STAPLEY

Director; Officer

1 sale — total 100,000 USD

Proposed sale 4 Jun 2026

Value US$100,000.00 | Price 48.69 | Shares 1,000

REBECCA CHAMBERS

Officer

1 sale — total 100,000 USD

Proposed sale 4 Jun 2026

Value US$100,000.00 | Price 48.69 | Shares 1,000

Wygant Jonathan

VP, Chief Accounting Officer

1 sale — total 100,000 USD

Sale 22 May 2026

Value US$100,000.00 | Price 45.40 | Shares 1,000

EPSTEIN ROBERT S

1 sale — total 100,000 USD

Planned sale 20 May 2026

Value US$100,000.00 | Price 44.01 | Shares 1,000

ROBERT EPSTEIN

Director

1 sale — total 100,000 USD

Proposed sale 20 May 2026

Value US$100,000.00 | Price 41.69 | Shares 1,000

McGuire Annie

SVP, General Counsel

2 sales — total 398,211 USD

Planned sale 6 May 2026

Value US$204,080.00 | Price 40.00 | Shares 5,102

Planned sale 6 May 2026

Value US$194,131.10 | Price 38.05 | Shares 5,102

ANN MCGUIRE

Officer

1 sale — total 336,426 USD

Proposed sale 6 May 2026

Value US$336,425.88 | Price 32.97 | Shares 10,204

McGuire Annie

SVP, General Counsel

2 sales — total 236,725 USD

Planned sale 4 Mar 2026

Value US$60,468.60 | Price 36.34 | Shares 1,664

Planned sale 4 Mar 2026

Value US$176,256.24 | Price 35.29 | Shares 4,994

Stapley Marc

Chief Executive Officer

2 sales — total 1,637,594 USD

Planned sale 4 Mar 2026

Value US$953,367.96 | Price 36.28 | Shares 26,279

Planned sale 4 Mar 2026

Value US$684,226.19 | Price 35.56 | Shares 19,244

Chambers Rebecca

Chief Financial Officer

2 sales — total 662,869 USD

Planned sale 4 Mar 2026

Value US$506,459.80 | Price 36.33 | Shares 13,941

Planned sale 4 Mar 2026

Value US$156,409.44 | Price 35.55 | Shares 4,400

Leite John

Chief Commercial Officer-CLIA

1 sale — total 185,083 USD

Planned sale 4 Mar 2026

Value US$185,082.57 | Price 35.19 | Shares 5,260

John Leite

Officer

1 sale — total 184,521 USD

Proposed sale 4 Mar 2026

Value US$184,520.80 | Price 35.08 | Shares 5,260

ANN MCGUIRE

Officer

1 sale — total 233,563 USD

Proposed sale 4 Mar 2026

Value US$233,562.64 | Price 35.08 | Shares 6,658

REBECCA CHAMBERS

Officer

1 sale — total 643,402 USD

Proposed sale 4 Mar 2026

Value US$643,402.28 | Price 35.08 | Shares 18,341

MARC STAPLEY

Director; Officer

1 sale — total 1,596,947 USD

Proposed sale 4 Mar 2026

Value US$1,596,946.84 | Price 35.08 | Shares 45,523

Febbo Phillip G.

Chief Scientific & Med Officer

1 sale — total 485,429 USD

Planned sale 2 Mar 2026

Value US$485,429.20 | Price 36.16 | Shares 13,425

PHILLIP FEBBO

Officer

1 sale — total 491,221 USD

Proposed sale 2 Mar 2026

Value US$491,220.75 | Price 36.59 | Shares 13,425

McGuire Annie

SVP, General Counsel

2 sales — total 463,204 USD

Planned sale 16 Dec 2025

Value US$4,368.00 | Price 43.68 | Shares 100

Planned sale 16 Dec 2025

Value US$458,835.60 | Price 43.13 | Shares 10,639

ANN MCGUIRE

Officer

1 sale — total 467,469 USD

Proposed sale 16 Dec 2025

Value US$467,468.67 | Price 43.53 | Shares 10,739

EASTHAM KARIN

3 sales — total 908,923 USD

Planned sale 5 Dec 2025

Value US$37,271.84 | Price 46.59 | Shares 800

Planned sale 5 Dec 2025

Value US$587,080.30 | Price 45.84 | Shares 12,808

Planned sale 5 Dec 2025

Value US$284,571.20 | Price 44.52 | Shares 6,392

KARIN EASTHAM

Director

1 sale — total 948,200 USD

Proposed sale 5 Dec 2025

Value US$948,200.00 | Price 47.41 | Shares 20,000

ANN MCGUIRE

Officer

1 sale — total 67,901 USD

Proposed sale 4 Dec 2025

Value US$67,900.50 | Price 47.75 | Shares 1,422

REBECCA CHAMBERS

Officer

1 sale — total 634,025 USD

Proposed sale 4 Dec 2025

Value US$634,024.50 | Price 47.75 | Shares 13,278

MARC STAPLEY

Director; Officer

1 sale — total 366,147 USD

Proposed sale 4 Dec 2025

Value US$366,147.00 | Price 47.75 | Shares 7,668

McGuire Annie

SVP, General Counsel

2 sales — total 67,261 USD

Planned sale 4 Dec 2025

Value US$33,352.02 | Price 47.51 | Shares 702

Planned sale 4 Dec 2025

Value US$33,908.76 | Price 47.10 | Shares 720

Leite John

Chief Commercial Officer-CLIA

1 sale — total 60,718 USD

Planned sale 4 Dec 2025

Value US$60,717.78 | Price 47.51 | Shares 1,278

Chambers Rebecca

Chief Financial Officer

2 sales — total 621,955 USD

Planned sale 4 Dec 2025

Value US$224,008.93 | Price 47.25 | Shares 4,741

Planned sale 4 Dec 2025

Value US$397,946.28 | Price 46.61 | Shares 8,537

Stapley Marc

Chief Executive Officer

2 sales — total 361,076 USD

Planned sale 4 Dec 2025

Value US$152,462.17 | Price 47.35 | Shares 3,220

Planned sale 4 Dec 2025

Value US$208,613.42 | Price 46.90 | Shares 4,448

Leite John

Chief Commercial Officer-CLIA

1 sale — total 140,400 USD

Planned sale 25 Nov 2025

Value US$140,400.00 | Price 50.00 | Shares 2,808

JONES EVAN/ FA

1 sale — total 55,576 USD

Planned sale 25 Nov 2025

Value US$55,575.73 | Price 50.25 | Shares 1,106

Evan Jones

Director

1 sale — total 246,900 USD

Proposed sale 25 Nov 2025

Value US$246,900.00 | Price 49.38 | Shares 5,000

John Leite

Officer

1 sale — total 190,816 USD

Proposed sale 25 Nov 2025

Value US$190,816.20 | Price 46.70 | Shares 4,086

Holstein Jens

3 sales — total 423,563 USD

Planned sale 20 Nov 2025

Value US$63,085.87 | Price 43.21 | Shares 1,460

Planned sale 20 Nov 2025

Value US$299,416.85 | Price 42.48 | Shares 7,049

Planned sale 20 Nov 2025

Value US$61,060.33 | Price 40.95 | Shares 1,491

JENS HOLSTEIN

Director

1 sale — total 423,563 USD

Proposed sale 20 Nov 2025

Value US$423,562.80 | Price 42.36 | Shares 10,000

Wygant Jonathan

VP, Chief Accounting Officer

1 sale — total 215,978 USD

Sale 10 Nov 2025

Value US$215,978.37 | Price 42.33 | Shares 5,102

Wygant Jonathan

VP, Chief Accounting Officer

1 sale — total 233,929 USD

Sale 7 Nov 2025

Value US$233,928.98 | Price 40.21 | Shares 5,818

EASTHAM KARIN

1 sale — total 387,191 USD

Planned sale 5 Nov 2025

Value US$387,191.21 | Price 40.02 | Shares 9,674

JONES EVAN/ FA

6 sales — total 1,946,288 USD

Planned sale 5 Nov 2025

Value US$30,468.77 | Price 46.38 | Shares 657

Planned sale 5 Nov 2025

Value US$1,110,990.48 | Price 45.73 | Shares 24,296

Planned sale 5 Nov 2025

Value US$264,640.47 | Price 45.07 | Shares 5,872

Planned sale 5 Nov 2025

Value US$474,701.78 | Price 43.80 | Shares 10,837

Planned sale 5 Nov 2025

Value US$48,455.05 | Price 43.03 | Shares 1,126

Planned sale 5 Nov 2025

Value US$17,031.18 | Price 41.74 | Shares 408

Chambers Rebecca

Chief Financial Officer

1 sale — total 287,000 USD

Planned sale 5 Nov 2025

Value US$287,000.00 | Price 41.00 | Shares 7,000

McGuire Annie

SVP, General Counsel

1 sale — total 258,640 USD

Planned sale 5 Nov 2025

Value US$258,640.00 | Price 40.00 | Shares 6,466

Evan Jones

Director

1 sale — total 1,988,744 USD

Proposed sale 5 Nov 2025

Value US$1,988,743.84 | Price 46.04 | Shares 43,196

KARIN EASTHAM

Director

1 sale — total 349,425 USD

Proposed sale 5 Nov 2025

Value US$349,424.88 | Price 36.12 | Shares 9,674

ANN MCGUIRE

Officer

1 sale — total 233,552 USD

Proposed sale 5 Nov 2025

Value US$233,551.92 | Price 36.12 | Shares 6,466

REBECCA CHAMBERS

Officer

1 sale — total 252,840 USD

Proposed sale 5 Nov 2025

Value US$252,840.00 | Price 36.12 | Shares 7,000

Febbo Phillip G.

Chief Scientific & Med Officer

1 sale — total 300,709 USD

Planned sale 6 Oct 2025

Value US$300,709.27 | Price 36.02 | Shares 8,349

PHILLIP FEBBO

Officer

1 sale — total 300,564 USD

Proposed sale 6 Oct 2025

Value US$300,564.00 | Price 36.00 | Shares 8,349

McGuire Annie

SVP, General Counsel

1 sale — total 75,608 USD

Planned sale 1 Oct 2025

Value US$75,607.56 | Price 35.00 | Shares 2,160

EPSTEIN ROBERT S

1 sale — total 753,204 USD

Planned sale 1 Oct 2025

Value US$753,204.13 | Price 35.08 | Shares 21,473

Leite John

Chief Commercial Officer-CLIA

1 sale — total 88,865 USD

Planned sale 1 Oct 2025

Value US$88,865.00 | Price 35.00 | Shares 2,539

ROBERT S EPSTEIN

Director

1 sale — total 737,168 USD

Proposed sale 1 Oct 2025

Value US$737,168.09 | Price 34.33 | Shares 21,473

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-06-04	2026-06-04	PlS Planned sale	2.6 Stapley Marc Chief Executive Officer Executive Director	5,387 -31.0% 173.23 US$745,922	5,387 -31.0%	173.23	US$745,922
2026-06-04	2026-06-04	PlS Planned sale	3.2 Leite John Global Chief Commercial Off Officer	50,014 -3.7% 403.65 US$4,416,297	50,014 -3.7%	403.65	US$4,416,297
2026-06-04	2026-06-04	PlS Planned sale	McGuire Annie EVP, General Counsel Officer	6,561 +48.8% 297.52 US$1,910,985	6,561 +48.8%	297.52	US$1,910,985
2026-06-04	2026-06-04	PlS Planned sale	McGuire Annie EVP, General Counsel Officer	1,000 -1.0% 49.31 US$100,000	1,000 -1.0%	49.31	US$100,000
2026-06-04	2026-06-04	PlS Planned sale	0.7 Chambers Rebecca Chief Financial Officer Officer	1,000 -1.1% 50.09 US$100,000	1,000 -1.1%	50.09	US$100,000
2026-06-04	2026-06-04	PlS Planned sale	0.7 Chambers Rebecca Chief Financial Officer Officer	1,000 -0.9% 49.28 US$100,000	1,000 -0.9%	49.28	US$100,000
2026-06-04	2026-06-04	PrS Proposed sale	ANN MCGUIRE Officer Officer	1,000 48.69 US$100,000	1,000	48.69	US$100,000
2026-06-04	2026-06-04	PrS Proposed sale	3.2 John Leite Officer Officer	1,000 48.69 US$100,000	1,000	48.69	US$100,000
2026-06-04	2026-06-04	PrS Proposed sale	2.6 MARC STAPLEY Director; Officer Executive Director	1,000 48.69 US$100,000	1,000	48.69	US$100,000
2026-06-04	2026-06-04	PrS Proposed sale	0.7 REBECCA CHAMBERS Officer Officer	1,000 48.69 US$100,000	1,000	48.69	US$100,000
2026-05-27	2026-05-22	S Sale	3.3 Wygant Jonathan VP, Chief Accounting Officer Officer	1,000 -34.6% 45.40 US$100,000	1,000 -34.6%	45.40	US$100,000
2026-05-22	2026-05-20	PlS Planned sale	EPSTEIN ROBERT S Non-Executive Director	1,000 -16.0% 44.01 US$100,000	1,000 -16.0%	44.01	US$100,000
2026-05-20	2026-05-20	PrS Proposed sale	ROBERT EPSTEIN Director Non-Executive Director	1,000 41.69 US$100,000	1,000	41.69	US$100,000
2026-05-08	2026-05-06	PlS Planned sale	McGuire Annie SVP, General Counsel Officer	5,102 -3.4% 40.00 US$204,080	5,102 -3.4%	40.00	US$204,080
2026-05-08	2026-05-06	PlS Planned sale	McGuire Annie SVP, General Counsel Officer	5,102 -3.3% 38.05 US$194,131	5,102 -3.3%	38.05	US$194,131
2026-05-06	2026-05-06	PrS Proposed sale	ANN MCGUIRE Officer Officer	10,204 32.97 US$336,426	10,204	32.97	US$336,426
2026-03-06	2026-03-04	PlS Planned sale	McGuire Annie SVP, General Counsel Officer	1,664 -1.7% 36.34 US$60,469	1,664 -1.7%	36.34	US$60,469
2026-03-06	2026-03-04	PlS Planned sale	McGuire Annie SVP, General Counsel Officer	4,994 -4.9% 35.29 US$176,256	4,994 -4.9%	35.29	US$176,256
2026-03-06	2026-03-04	PlS Planned sale	2.6 Stapley Marc Chief Executive Officer Executive Director	26,279 -6.8% 36.28 US$953,368	26,279 -6.8%	36.28	US$953,368
2026-03-06	2026-03-04	PlS Planned sale	2.6 Stapley Marc Chief Executive Officer Executive Director	19,244 -4.8% 35.56 US$684,226	19,244 -4.8%	35.56	US$684,226
2026-03-06	2026-03-04	PlS Planned sale	0.7 Chambers Rebecca Chief Financial Officer Officer	13,941 -9.6% 36.33 US$506,460	13,941 -9.6%	36.33	US$506,460
2026-03-06	2026-03-04	PlS Planned sale	0.7 Chambers Rebecca Chief Financial Officer Officer	4,400 -2.9% 35.55 US$156,409	4,400 -2.9%	35.55	US$156,409
2026-03-06	2026-03-04	PlS Planned sale	3.2 Leite John Chief Commercial Officer-CLIA Officer	5,260 -4.7% 35.19 US$185,083	5,260 -4.7%	35.19	US$185,083
2026-03-04	2026-03-04	PrS Proposed sale	3.2 John Leite Officer Officer	5,260 35.08 US$184,521	5,260	35.08	US$184,521
2026-03-04	2026-03-04	PrS Proposed sale	ANN MCGUIRE Officer Officer	6,658 35.08 US$233,563	6,658	35.08	US$233,563
2026-03-04	2026-03-04	PrS Proposed sale	0.7 REBECCA CHAMBERS Officer Officer	18,341 35.08 US$643,402	18,341	35.08	US$643,402
2026-03-04	2026-03-04	PrS Proposed sale	2.6 MARC STAPLEY Director; Officer Executive Director	45,523 35.08 US$1,596,947	45,523	35.08	US$1,596,947
2026-03-04	2026-03-02	PlS Planned sale	Febbo Phillip G. Chief Scientific & Med Officer Officer	13,425 -10.3% 36.16 US$485,429	13,425 -10.3%	36.16	US$485,429
2026-03-02	2026-03-02	PrS Proposed sale	PHILLIP FEBBO Officer Officer	13,425 36.59 US$491,221	13,425	36.59	US$491,221
2025-12-17	2025-12-16	PlS Planned sale	McGuire Annie SVP, General Counsel Officer	100 -0.1% 43.68 US$4,368	100 -0.1%	43.68	US$4,368
2025-12-17	2025-12-16	PlS Planned sale	McGuire Annie SVP, General Counsel Officer	10,639 -13.6% 43.13 US$458,836	10,639 -13.6%	43.13	US$458,836
2025-12-16	2025-12-16	PrS Proposed sale	ANN MCGUIRE Officer Officer	10,739 43.53 US$467,469	10,739	43.53	US$467,469
2025-12-08	2025-12-05	PlS Planned sale	EASTHAM KARIN Non-Executive Director	800 -5.6% 46.59 US$37,272	800 -5.6%	46.59	US$37,272
2025-12-08	2025-12-05	PlS Planned sale	EASTHAM KARIN Non-Executive Director	12,808 -47.2% 45.84 US$587,080	12,808 -47.2%	45.84	US$587,080
2025-12-08	2025-12-05	PlS Planned sale	EASTHAM KARIN Non-Executive Director	6,392 -19.0% 44.52 US$284,571	6,392 -19.0%	44.52	US$284,571
2025-12-05	2025-12-05	PrS Proposed sale	KARIN EASTHAM Director Non-Executive Director	20,000 47.41 US$948,200	20,000	47.41	US$948,200
2025-12-04	2025-12-04	PrS Proposed sale	ANN MCGUIRE Officer Officer	1,422 47.75 US$67,900	1,422	47.75	US$67,900
2025-12-04	2025-12-04	PrS Proposed sale	0.7 REBECCA CHAMBERS Officer Officer	13,278 47.75 US$634,024	13,278	47.75	US$634,024
2025-12-04	2025-12-04	PrS Proposed sale	2.6 MARC STAPLEY Director; Officer Executive Director	7,668 47.75 US$366,147	7,668	47.75	US$366,147
2025-12-04	2025-12-04	PlS Planned sale	McGuire Annie SVP, General Counsel Officer	702 -0.9% 47.51 US$33,352	702 -0.9%	47.51	US$33,352
2025-12-04	2025-12-04	PlS Planned sale	McGuire Annie SVP, General Counsel Officer	720 -0.9% 47.10 US$33,909	720 -0.9%	47.10	US$33,909
2025-12-04	2025-12-04	PlS Planned sale	3.2 Leite John Chief Commercial Officer-CLIA Officer	1,278 -1.5% 47.51 US$60,718	1,278 -1.5%	47.51	US$60,718
2025-12-04	2025-12-04	PlS Planned sale	0.7 Chambers Rebecca Chief Financial Officer Officer	4,741 -4.2% 47.25 US$224,009	4,741 -4.2%	47.25	US$224,009
2025-12-04	2025-12-04	PlS Planned sale	0.7 Chambers Rebecca Chief Financial Officer Officer	8,537 -7.0% 46.61 US$397,946	8,537 -7.0%	46.61	US$397,946
2025-12-04	2025-12-04	PlS Planned sale	2.6 Stapley Marc Chief Executive Officer Executive Director	3,220 -1.0% 47.35 US$152,462	3,220 -1.0%	47.35	US$152,462
2025-12-04	2025-12-04	PlS Planned sale	2.6 Stapley Marc Chief Executive Officer Executive Director	4,448 -1.4% 46.90 US$208,613	4,448 -1.4%	46.90	US$208,613
2025-11-26	2025-11-25	PlS Planned sale	3.2 Leite John Chief Commercial Officer-CLIA Officer	2,808 -3.2% 50.00 US$140,400	2,808 -3.2%	50.00	US$140,400
2025-11-26	2025-11-25	PlS Planned sale	1.6 JONES EVAN/ FA Non-Executive Director	1,106 -3.6% 50.25 US$55,576	1,106 -3.6%	50.25	US$55,576
2025-11-25	2025-11-25	PrS Proposed sale	1.6 Evan Jones Director Non-Executive Director	5,000 49.38 US$246,900	5,000	49.38	US$246,900
2025-11-25	2025-11-25	PrS Proposed sale	3.2 John Leite Officer Officer	4,086 46.70 US$190,816	4,086	46.70	US$190,816
2025-11-21	2025-11-20	PlS Planned sale	1.5 Holstein Jens Non-Executive Director	1,460 -5.1% 43.21 US$63,086	1,460 -5.1%	43.21	US$63,086
2025-11-21	2025-11-20	PlS Planned sale	1.5 Holstein Jens Non-Executive Director	7,049 -19.7% 42.48 US$299,417	7,049 -19.7%	42.48	US$299,417
2025-11-21	2025-11-20	PlS Planned sale	1.5 Holstein Jens Non-Executive Director	1,491 -4.0% 40.95 US$61,060	1,491 -4.0%	40.95	US$61,060
2025-11-20	2025-11-20	PrS Proposed sale	1.5 JENS HOLSTEIN Director Non-Executive Director	10,000 42.36 US$423,563	10,000	42.36	US$423,563
2025-11-12	2025-11-10	S Sale	3.3 Wygant Jonathan VP, Chief Accounting Officer Officer	5,102 -11.6% 42.33 US$215,978	5,102 -11.6%	42.33	US$215,978
2025-11-12	2025-11-07	S Sale	3.3 Wygant Jonathan VP, Chief Accounting Officer Officer	5,818 -11.7% 40.21 US$233,929	5,818 -11.7%	40.21	US$233,929
2025-11-07	2025-11-05	PlS Planned sale	EASTHAM KARIN Non-Executive Director	9,674 -41.6% 40.02 US$387,191	9,674 -41.6%	40.02	US$387,191
2025-11-07	2025-11-05	PlS Planned sale	1.6 JONES EVAN/ FA Non-Executive Director	657 -2.1% 46.38 US$30,469	657 -2.1%	46.38	US$30,469
2025-11-07	2025-11-05	PlS Planned sale	1.6 JONES EVAN/ FA Non-Executive Director	24,296 -43.8% 45.73 US$1,110,990	24,296 -43.8%	45.73	US$1,110,990
2025-11-07	2025-11-05	PlS Planned sale	1.6 JONES EVAN/ FA Non-Executive Director	5,872 -9.6% 45.07 US$264,640	5,872 -9.6%	45.07	US$264,640
2025-11-07	2025-11-05	PlS Planned sale	1.6 JONES EVAN/ FA Non-Executive Director	10,837 -15.0% 43.80 US$474,702	10,837 -15.0%	43.80	US$474,702
2025-11-07	2025-11-05	PlS Planned sale	1.6 JONES EVAN/ FA Non-Executive Director	1,126 -1.5% 43.03 US$48,455	1,126 -1.5%	43.03	US$48,455
2025-11-07	2025-11-05	PlS Planned sale	1.6 JONES EVAN/ FA Non-Executive Director	408 -0.6% 41.74 US$17,031	408 -0.6%	41.74	US$17,031
2025-11-07	2025-11-05	PlS Planned sale	0.7 Chambers Rebecca Chief Financial Officer Officer	7,000 -5.3% 41.00 US$287,000	7,000 -5.3%	41.00	US$287,000
2025-11-07	2025-11-05	PlS Planned sale	McGuire Annie SVP, General Counsel Officer	6,466 -7.2% 40.00 US$258,640	6,466 -7.2%	40.00	US$258,640
2025-11-05	2025-11-05	PrS Proposed sale	1.6 Evan Jones Director Non-Executive Director	43,196 46.04 US$1,988,744	43,196	46.04	US$1,988,744
2025-11-05	2025-11-05	PrS Proposed sale	KARIN EASTHAM Director Non-Executive Director	9,674 36.12 US$349,425	9,674	36.12	US$349,425
2025-11-05	2025-11-05	PrS Proposed sale	ANN MCGUIRE Officer Officer	6,466 36.12 US$233,552	6,466	36.12	US$233,552
2025-11-05	2025-11-05	PrS Proposed sale	0.7 REBECCA CHAMBERS Officer Officer	7,000 36.12 US$252,840	7,000	36.12	US$252,840
2025-10-07	2025-10-06	PlS Planned sale	Febbo Phillip G. Chief Scientific & Med Officer Officer	8,349 -8.3% 36.02 US$300,709	8,349 -8.3%	36.02	US$300,709
2025-10-06	2025-10-06	PrS Proposed sale	PHILLIP FEBBO Officer Officer	8,349 36.00 US$300,564	8,349	36.00	US$300,564
2025-10-03	2025-10-01	PlS Planned sale	McGuire Annie SVP, General Counsel Officer	2,160 -2.4% 35.00 US$75,608	2,160 -2.4%	35.00	US$75,608
2025-10-03	2025-10-01	PlS Planned sale	EPSTEIN ROBERT S Non-Executive Director	21,473 -25.6% 35.08 US$753,204	21,473 -25.6%	35.08	US$753,204
2025-10-03	2025-10-01	PlS Planned sale	3.2 Leite John Chief Commercial Officer-CLIA Officer	2,539 -2.8% 35.00 US$88,865	2,539 -2.8%	35.00	US$88,865
2025-10-01	2025-10-01	PrS Proposed sale	ROBERT S EPSTEIN Director Non-Executive Director	21,473 34.33 US$737,168	21,473	34.33	US$737,168